11.78
price down icon8.96%   -1.16
after-market Handel nachbörslich: 11.78
loading
Schlusskurs vom Vortag:
$12.94
Offen:
$12.94
24-Stunden-Volumen:
61,412
Relative Volume:
0.69
Marktkapitalisierung:
$146.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-11.33
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
-9.38%
1M Leistung:
-23.95%
6M Leistung:
+69.25%
1J Leistung:
+181.82%
1-Tages-Spanne:
Value
$11.58
$13.46
1-Wochen-Bereich:
Value
$11.58
$15.10
52-Wochen-Spanne:
Value
$4.12
$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
Firmenname
Forte Biosciences Inc
Name
Telefon
(310) 618-6994
Name
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
Mitarbeiter
17
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
FBRX's Discussions on Twitter

Vergleichen Sie FBRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FBRX
Forte Biosciences Inc
11.78 160.88M 0 -31.48M -28.71M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-18 Eingeleitet Guggenheim Buy
2025-01-21 Eingeleitet TD Cowen Buy
2024-04-08 Hochstufung Ladenburg Thalmann Neutral → Buy
2021-09-20 Hochstufung Chardan Capital Markets Sell → Buy
2021-09-03 Herabstufung B. Riley Securities Buy → Neutral
2021-09-03 Herabstufung Chardan Capital Markets Buy → Sell
2021-09-03 Herabstufung Ladenburg Thalmann Buy → Neutral
2021-09-03 Herabstufung Truist Buy → Hold
2021-05-14 Eingeleitet B. Riley Securities Buy
2021-03-26 Eingeleitet Citigroup Buy
2020-08-28 Hochstufung Chardan Capital Markets Neutral → Buy
2020-08-25 Eingeleitet Truist Buy
Alle ansehen

Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten

pulisher
Nov 03, 2025

Why Forte Biosciences Inc. stock is in analyst buy zone2025 Price Targets & Long Hold Capital Preservation Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Forte Biosciences Inc. stock reacts to Fed rate cutsMarket Volume Report & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short Interest - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences - Bluefield Daily Telegraph

Nov 03, 2025
pulisher
Nov 03, 2025

Forte Bio (NASDAQ: FBRX) to present at Guggenheim, TD Cowen, Evercore in Nov-Dec - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

How Forte Biosciences Inc. stock performs after earningsJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Forte Biosciences Inc. stock appeals to analystsSell Signal & Precise Swing Trade Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Signal strength of Forte Biosciences Inc. stock in tech scannersJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Forte Biosciences Inc. stock affected by interest rate hikes2025 Technical Overview & High Accuracy Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Detecting support and resistance levels for Forte Biosciences Inc.Jobs Report & Expert Curated Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

News impact scoring models applied to Forte Biosciences Inc.Quarterly Performance Summary & Technical Entry and Exit Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Forte Biosciences, Inc. $FBRX Stake Boosted by AlphaQuest LLC - Defense World

Nov 03, 2025
pulisher
Nov 03, 2025

What analyst consensus implies for Forte Biosciences Inc. (37T) stockPortfolio Risk Summary & Reliable Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Forte Biosciences Inc. (37T) stock appeals to dividend investorsPortfolio Return Report & Entry and Exit Point Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How strong is Forte Biosciences Inc. stock balance sheetGlobal Markets & AI Enhanced Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How Forte Biosciences Inc. stock performs in interest rate cyclesWeekly Trading Summary & Risk Controlled Stock Pick Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How to interpret RSI for Forte Biosciences Inc. stockJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Smart tools for monitoring Forte Biosciences Inc.’s price action2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Forte Biosciences (NASDAQ:FBRX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

What analysts say about Forte Biosciences Inc stockMarket Volatility Update & Free High Impact Stock Picks - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Weiss Ratings Reaffirms "Sell (E+)" Rating for Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

How Forte Biosciences Inc. stock performs in rate cut cycles2025 Price Targets & Long-Term Investment Growth Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Investors Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Will Forte Biosciences Inc. stock outperform growth indexesPortfolio Gains Report & Consistent Income Trade Ideas - newser.com

Oct 31, 2025

Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):